Risk of Cardiovascular Events, Malignancy, and Serious Infection Associated with JAK Inhibitors and TNF Inhibitors in Rheumatoid Arthritis or Ulcerative Colitis: A Nationwide Cohort Study

被引：0
|
作者：
Cho, Yongtai [1 ]
Yoon, Dongwon [2 ]
Khosrow-Khavar, Farzin [3 ]
Song, Minkyo [4 ]
Kim, Ju Hwan [1 ]
Shin, Ju-Young [1 ]
机构：
[1] Sungkyunkwan Univ, Sch Pharm, Suwon, South Korea
[2] NIA, NIH, Bethesda, MD USA
[3] Rutgers State Univ, New Brunswick, NJ USA
[4] NIA, NIH, Lab Epidemiol & Populat Sci, Bethesda, MD USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
73
引用
收藏
页码：9 / 9
页数：1
相关论文
共 50 条
  • [31] RISK MODIFICATION OF TUBERCULOSIS INFECTION BY CHEMOPROPHYLAXIS AMONG PATIENTS WITH RHEUMATOID ARTHRITIS RECEIVING TNF INHIBITORS: A NATION-WIDE COHORT STUDY
    Shin, A.
    Park, E. H.
    Ha, Y. J.
    Lee, Y. J.
    Song, Y. W.
    Kang, E. H.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 303 - 304
  • [32] How Fast Do JAK-inhibitors, TNF- inhibitors, Abatacept and IL-6 Inhibitors Act in Rheumatoid Arthritis? An International Collaboration of Registers of Rheumatoid Arthritis Patients (the "JAK-pot" Study)
    Courvoisier, Delphine Sophie
    Mrad, Yacine
    Mongin, Denis
    Aymon, Romain
    Caporali, Roberto
    Choquette, Denis
    Codreanu, Catalin
    Coupal, Louis
    Huschek, Doreen
    Hyrich, Kimme
    Iannone, Florenzo
    Kvien, Tore K.
    Mustak, Monika
    Nordstrom, Dan
    Trokovic, Nina
    Otero-Varela, Lucia
    Pavelka, Karel
    Suarez, Manuel Enrique Pombo
    Provan, Sella A.
    Rodrigues, Ana Maria
    Rotar, Ziga
    Sidiropoulos, Prodromos
    Strangfeld, Anja
    Zavada, Jakub
    Zhao, Sizheng
    Finckh, Axel
    Lauper, Kim
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1014 - 1017
  • [33] Use of varenicline for smoking cessation and risk of serious cardiovascular events: nationwide cohort study
    Svanstrom, Henrik
    Pasternak, Bjorn
    Hviid, Anders
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 345
  • [34] Co-morbidities increase the risk of serious infections in patients with rheumatoid arthritis treated with TNFα inhibitors
    Davas, Evangelos M.
    Alexiou, Ioannis
    Boulbou, Mary
    Koutroumpas, Athanasios
    Makaritsis, Konstantinos
    Stathakis, Nikolaos
    Sakkas, Lazaros I.
    JOURNAL OF INFECTION, 2008, 57 (05) : 418 - 420
  • [35] CANCER RISK IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH JANUS KINASE INHIBITORS: A NATIONWIDE DANISH REGISTERBASED COHORT STUDY
    Westermann, R.
    Cordtz, R. L.
    Duch, K.
    Mellemkjaer, L.
    Hetland, M. L.
    Burden, A. M.
    Hejlesen, O.
    Bogsted, M.
    Dreyer, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 708 - 709
  • [36] MICROSCOPIC COLITIS AND FUTURE RISK OF RHEUMATOID ARTHRITIS: A NATIONWIDE MATCHED COHORT STUDY.
    Bergman, David
    Khalili, Hamed
    Ebrahimi, Fahim
    Sun, Jiangwei
    Roelstraete, Bjorn
    Askling, Johan
    Ludvigsson, Jonas F.
    GASTROENTEROLOGY, 2023, 164 (06) : S430 - S430
  • [37] Risk of Serious Infection Among Initiators of Tumor Necrosis Factor Inhibitors Plus Methotrexate Versus Triple Therapy for Rheumatoid Arthritis: A Cohort Study
    Kang, Eun Ha
    Jin, Yinzhu
    Tong, Angela Y.
    Desai, Rishi J.
    Kim, Seoyoung C.
    ARTHRITIS CARE & RESEARCH, 2020, 72 (10) : 1383 - 1391
  • [38] Evaluate the risk of cardiovascular event in rheumatoid arthritis patient receiving tofacitinib and TNF inhibitors in Taiwan
    Shen, Chin-Yao
    Lai, Edward
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 278 - 279
  • [39] Risk of Serious Infection Associated with TNF Inhibitor Versus Triple Therapy in Rheumatoid Arthritis Patients
    Jin, Yinzhu
    Kang, Eun Ha
    Desai, Rishi J.
    Tong, Angela
    Kim, Seoyoung C.
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [40] RISK OF CARDIOVASCULAR AND VENOUS THROMBOEMBOLISM EVENTS AMONG JAK INHIBITORS USED IN RHEUMATOID ARTHRITIS: A NETWORK META-ANALYSIS OF CLINICAL TRIALS
    Penedones, Ana
    Alves, Carlos
    Mendes, Diogo
    Batel-Marques, Francisco
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (SUPPL 1) : 25 - 25
12345